Evidence map›Paper›PMID 38843285›Full record

ArticlePLoS neglected tropical diseases2024

Acceptability and feasibility of tests for infection, serological testing, and photography to define need for interventions against trachoma.

Kristen K Renneker, Tara B Mtuy, George Kabona, Stephen Gabriel Mbwambo, Patrick Mosha, Jeremiah Mepukori Mollel, P J Hooper, Paul M Emerson, T Deirdre Hollingsworth, Robert Butcher and 2 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kristen K RennekerClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0001-8036-4776
Tara B MtuyClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
George KabonaNational Neglected Tropical Diseases Control Programme, Preventive Services Department, Ministry of Health, Dodoma, Tanzania.
Stephen Gabriel MbwamboNational Neglected Tropical Diseases Control Programme, Preventive Services Department, Ministry of Health, Dodoma, Tanzania.
Patrick MoshaInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, United States of America.
Jeremiah Mepukori MollelInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, United States of America.
P J HooperInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, United States of America.
Paul M EmersonInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, United States of America.
T Deirdre HollingsworthBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Robert ButcherClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Anthony W SolomonGlobal Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.
Emma M Harding-EschClinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Funding

Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

backgroundTrachoma causes blindness due to repeated conjunctival infection by Chlamydia trachomatis (Ct). Transmission intensity is estimated, for programmatic decision-making, by prevalence of the clinical sign trachomatous inflammation-follicular (TF) in children aged 1-9 years. Research into complementary indicators to field-graded TF includes work on conjunctival photography, tests for ocular Ct infection, and serology. The perceived acceptability and feasibility of these indicators among a variety of stakeholders is unknown. METHODOLOGY: Focus group discussions (FGDs) with community members and in-depth interviews (IDIs) with public health practitioners in Tanzania were conducted. FGDs explored themes including participants' experience with, and thoughts about, different diagnostic approaches. The framework method for content analysis was used. IDIs yielded lists of perceived strengths of, and barriers to, implementation for programmatic use of each indicator. These were used to form an online quantitative survey on complementary indicators distributed to global stakeholders via meetings, mailing lists, and social media posts.

resultsSixteen FGDs and 11 IDIs were conducted in October-November 2022. In general, all proposed sample methods were deemed acceptable by community members. Common themes included not wanting undue discomfort and a preference for tests perceived as accurate. Health workers noted the importance of community education for some sample types. The online survey was conducted in April-May 2023 with 98 starting the questionnaire and 81 completing it. Regarding barriers to implementing diagnostics, the highest agreement items related to feasibility, rather than acceptability. No evidence of significant differences was found in responses pertaining to community acceptability based on participant characteristics.

conclusionsAll of the indicators included were generally deemed acceptable by all stakeholders in Tanzania, although community education around the benefits and risks of different sample types, as well as addressing issues around feasibility, will be key to successful, sustainable integration of these indicators into trachoma programs.

Indexed as

PhotographyTrachomaAdolescentAdultChildChild, PreschoolChlamydia trachomatisFeasibility StudiesFemaleFocus GroupsHumansInfantMaleMiddle AgedSerologic TestsTanzania

Identifiers

PMID38843285
PMCPMC11185441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.